Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†-Reference-Cited by-同舟云学术

Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†

Published:2023-02 Issue:1 Volume:16 Page:
ISSN:2574-8300
Container-title:Circulation: Genomic and Precision Medicine
language:en
Short-container-title:Circ: Genomic and Precision Medicine

Author:

Machipisa Tafadzwa¹²³⁴⁵^ORCID,Chishala Chishala¹⁶,Shaboodien Gasnat¹²^ORCID,Zühlke Liesl J.¹²⁷⁸,Muhamed Babu¹²³⁴⁵,Pandie Shahiemah¹^ORCID,de Vries Jantina¹,Laing Nakita¹^ORCID,Joachim Alexia¹^ORCID,Daniels Rezeen¹,Ntsekhe Mpiko¹^ORCID,Hugo-Hamman Christopher T.⁹,Gitura Bernard¹⁰,Ogendo Stephen¹¹,Lwabi Peter¹²^ORCID,Okello Emmy¹²,Damasceno Albertino¹³^ORCID,Novela Celia¹³,Mocumbi Ana O.¹⁴^ORCID,Madeira Geoffrey¹⁵,Musuku John¹⁶,Mtaja Agnes¹⁶,ElSayed Ahmed¹⁷,Alhassan Huda H.M.¹⁷,Bode-Thomas Fidelia¹⁸,Yilgwan Christopher¹⁸^ORCID,Amusa Ganiyu¹⁸^ORCID,Nkereuwem Esin¹⁸^ORCID,Mulder Nicola¹⁹,Ramesar Raj²⁰^ORCID,Lesosky Maia²¹^ORCID,Cordell Heather J.²²^ORCID,Chong Michael³⁴⁵^ORCID,Keavney Bernard²³²⁴^ORCID,Paré Guillaume³⁴⁵²⁵^ORCID,Engel Mark E.¹²^ORCID,

Affiliation:

1. Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa (T.M., C.C., G.S., L.J.Z., B.M., S.P.; J.d.V., N.L., A.J., R.D., M.N., M.E.E.).

2. Department of Medicine, Cape Heart Institute, University of Cape Town, Cape Town, South Africa (T.M., G.S., L.J.Z., B.M., M.E.E.).

3. Population Health Research Institute, Hamilton, ON, Canada (T.M., B.M., M.C., G.P.).

4. Thrombosis and Atherosclerosis Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton, ON, Canada (T.M., B.M., M.C., G.P.).

5. Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, Hamilton, ON, Canada (T.M., B.M., M.C., G.P.).

6. Division of Cardiology, University of KwaZulu-Natal, Msunduzi, KwaZulu-Natal (C.C.).

7. Division of Pediatric Cardiology, Department of Pediatrics and Child Health, Red Cross War Memorial Children’s Hospital, Cape Town, South Africa (L.J.Z.).

8. South African Medical Research Council, Extramural Research and Internal Portfolio, Cape Town, South Africa (L.J.Z.).

9. Rheumatic Heart Disease Clinic, Windhoek Central Hospital, Ministry of Health and Social Services, Windhoek, Republic of Namibia (C.T.H.-H.).

10. Cardiology Department of Medicine, Kenyatta National Hospital, University of Nairobi, Nairobi, Kenya (B.G.).

11. Uganda Heart Inst, Departments of Adult and Pediatric Cardiology, Kampala, Uganda (S.O.).

12. School of Medicine, Maseno Univ, Kenya (P.L., E.O.).

13. Faculty of Medicine, Eduardo Mondlane Univ/Nucleo de Investigaçao, Departamento de Medicina, Hospital Central de Maputo, Maputo, Mozambique (A.D., C.N.).

14. Instituto Nacional de Saúde Ministério da Saúde, Mozambique (A.O.M.).

15. WHO Mozambique, Maputo, Mozambique (G.M.).

16. University Teaching Hospital, Children’s Hospital, University of Zambia, Lusaka, Zambia (J.M., A.M.).

17. Department of Cardiothoracic Surgery, Alshaab Teaching Hospital, Alazhari Health Research Centre, Alzaiem Alazhari University, Khartoum, Sudan (A.E., H.H.M.A.).

18. Deptartments of Pediatrics and Medicine, Jos University Teaching Hospital and University of Jos, Jos, Plateau State, Nigeria (F.B.-T., C.Y., G.A., E.N.).

19. Computational Biology Division, Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences (N.M.), University of Cape Town, Cape Town, South Africa.

20. Department of Pathology (R.R.), University of Cape Town, Cape Town, South Africa.

21. Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine (M.L.), University of Cape Town, Cape Town, South Africa.

22. Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK (H.J.C.).

23. Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, UK (B.K.).

24. Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, UK (B.K.).

25. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada (G.P.).

Abstract

Background: The genetics of rheumatic heart disease (RHDGen) Network was developed to assist the discovery and validation of genetic variations and biomarkers of risk for rheumatic heart disease (RHD) in continental Africans, as a part of the global fight to control and eradicate rheumatic fever/RHD. Thus, we describe the rationale and design of the RHDGen study, comprising participants from 8 African countries. Methods: RHDGen screened potential participants using echocardiography, thereafter enrolling RHD cases and ethnically-matched controls for whom case characteristics were documented. Biological samples were collected for conducting genetic analyses, including a discovery case-control genome-wide association study (GWAS) and a replication trio family study. Additional biological samples were also collected, and processed, for the measurement of biomarker analytes and the biomarker analyses are underway. Results: Participants were enrolled into RHDGen between December 2012 and March 2018. For GWAS, 2548 RHD cases and 2261 controls (3301 women [69%]; mean age [SD], 37 [16.3] years) were available. RHD cases were predominantly Black (66%), Admixed (24%), and other ethnicities (10%). Among RHD cases, 34% were asymptomatic, 26% had prior valve surgery, and 23% had atrial fibrillation. The trio family replication arm included 116 RHD trio probands and 232 parents. Conclusions: RHDGen presents a rare opportunity to identify relevant patterns of genetic factors and biomarkers in Africans that may be associated with differential RHD risk. Furthermore, the RHDGen Network provides a platform for further work on fully elucidating the causes and mechanisms associated with RHD susceptibility and development.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference49 articles.

1. The American Heart Association’s Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association

2. Tissot, C, da Cruz, EM, Kalangos, A, Buckvold, S, Myers, PO. Mitral Valve Anomalies and Related Disorders Critical Care of Children with Heart Disease. Springer; 2020.

3. Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective

4. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

5. World Health Organization. Rheumatic fever and rheumatic heart disease 2018: Executive Board 141st Session: Resolutions and decisions annexes summary records. Geneva Switzerland. Available at: https://www.who.int/cardiovascular_diseases/publications/trs923/en/